{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Control+regimen&page=10", "query": { "intervention": "Control regimen", "page": 10 }, "page_size": 10 }, "pagination": { "page": 10, "page_size": 10, "total_count": 1564, "total_pages": 157, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Control+regimen&page=11&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Control+regimen&page=9&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-27T16:34:52.595Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT04829682", "title": "Testing the Efficacy of ACT for Life", "overall_status": "ENROLLING_BY_INVITATION", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Suicide" ], "interventions": [ { "name": "ACT for Life", "type": "BEHAVIORAL" }, { "name": "Present Centered Therapy", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "VA Office of Research and Development", "sponsor_class": "FED", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "89 Years", "sex": "ALL", "summary": "18 Years to 89 Years" }, "enrollment_count": 278, "start_date": "2022-10-01", "completion_date": "2027-03-31", "has_results": false, "last_update_posted_date": "2026-04-14", "last_synced_at": "2026-10-27T16:34:52.595Z", "location_count": 2, "location_summary": "Aurora, Colorado • Battle Creek, Michigan", "locations": [ { "city": "Aurora", "state": "Colorado" }, { "city": "Battle Creek", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT04829682" }, { "nct_id": "NCT02260986", "title": "Study to Assess the Efficacy and Long-term Safety of Dupilumab (REGN668/SAR231893) in Adult Participants With Moderate-to-Severe Atopic Dermatitis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Atopic Dermatitis" ], "interventions": [ { "name": "Dupilumab", "type": "DRUG" }, { "name": "Placebo (for Dupilumab)", "type": "DRUG" }, { "name": "Topical Corticosteroid (TCS)", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Regeneron Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 740, "start_date": "2014-09", "completion_date": "2016-10", "has_results": true, "last_update_posted_date": "2017-10-17", "last_synced_at": "2026-10-27T16:34:52.595Z", "location_count": 50, "location_summary": "Phoenix, Arizona • Hot Springs, Arkansas • Little Rock, Arkansas + 47 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Hot Springs", "state": "Arkansas" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Encinitas", "state": "California" }, { "city": "Oceanside", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02260986" }, { "nct_id": "NCT02609594", "title": "Amnioband and Standard of Care vs. Standard of Care Alone in the Treatment of Venous Leg Ulcers", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Venous Leg Ulcers" ], "interventions": [ { "name": "Weekly application of Amnioband", "type": "OTHER" }, { "name": "Biweekly application of Amnioband", "type": "OTHER" }, { "name": "Standard of Care", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "SerenaGroup, Inc.", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 240, "start_date": "2015-11", "completion_date": "2018-12", "has_results": false, "last_update_posted_date": "2018-09-07", "last_synced_at": "2026-10-27T16:34:52.595Z", "location_count": 8, "location_summary": "Boston, Massachusetts • Brick, New Jersey • Elmer, New Jersey + 5 more", "locations": [ { "city": "Boston", "state": "Massachusetts" }, { "city": "Brick", "state": "New Jersey" }, { "city": "Elmer", "state": "New Jersey" }, { "city": "Tulsa", "state": "Oklahoma" }, { "city": "Ford City", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT02609594" }, { "nct_id": "NCT07852611", "title": "Auricular Point Acupressure for Pain", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "HIV (Human Immunodeficiency Virus)", "Pain" ], "interventions": [ { "name": "Auricular Point Acupressure", "type": "OTHER" }, { "name": "Sham Auricular Point Acupressure", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Dan Song", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "50 Years", "maximum_age": null, "sex": "ALL", "summary": "50 Years and older" }, "enrollment_count": 30, "start_date": "2026-10", "completion_date": "2027-09", "has_results": false, "last_update_posted_date": "2026-10-01", "last_synced_at": "2026-10-27T16:34:52.595Z", "location_count": 1, "location_summary": "Corpus Christi, Texas", "locations": [ { "city": "Corpus Christi", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT07852611" }, { "nct_id": "NCT05271487", "title": "A Botanical Skin Care Regimen on Mild to Moderate Acne and the Microbiome", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Acne Vulgaris" ], "interventions": [ { "name": "Multi-Step Botanical Skin Care Regimen", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Integrative Skin Science and Research", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "15 Years", "maximum_age": "45 Years", "sex": "ALL", "summary": "15 Years to 45 Years" }, "enrollment_count": 20, "start_date": "2022-03-07", "completion_date": "2023-03-01", "has_results": false, "last_update_posted_date": "2022-03-09", "last_synced_at": "2026-10-27T16:34:52.595Z", "location_count": 1, "location_summary": "Sacramento, California", "locations": [ { "city": "Sacramento", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05271487" }, { "nct_id": "NCT06525701", "title": "Surgeon Core-strengthening Program as a Modifier for Exertion Associated With Vaginal Surgery", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Musculoskeletal Pain", "Musculoskeletal Injury" ], "interventions": [ { "name": "Execise Group", "type": "OTHER" }, { "name": "Control Group", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Loyola University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 18, "start_date": "2024-08-12", "completion_date": "2025-07-01", "has_results": false, "last_update_posted_date": "2025-09-09", "last_synced_at": "2026-10-27T16:34:52.595Z", "location_count": 1, "location_summary": "Maywood, Illinois", "locations": [ { "city": "Maywood", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT06525701" }, { "nct_id": "NCT01106014", "title": "Selexipag (ACT-293987) in Pulmonary Arterial Hypertension", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Pulmonary Arterial Hypertension" ], "interventions": [ { "name": "Selexipag", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Actelion", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 1156, "start_date": "2009-12-01", "completion_date": "2014-10-01", "has_results": true, "last_update_posted_date": "2025-10-27", "last_synced_at": "2026-10-27T16:34:52.595Z", "location_count": 43, "location_summary": "Mobile, Alabama • Tucson, Arizona • La Jolla, California + 32 more", "locations": [ { "city": "Mobile", "state": "Alabama" }, { "city": "Tucson", "state": "Arizona" }, { "city": "La Jolla", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01106014" }, { "nct_id": "NCT07625644", "title": "BL-M14D1 Plus Atezolizumab vs Standard of Care in First-Line Extensive-Stage Small Cell Lung Cancer (BrenDeLL-Lung01)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Small Cell Lung Cancer Extensive Stage", "Small-cell Lung Cancer", "Small Cell Carcinoma", "Sclc", "SCLC,Extensive Stage", "Lung Cancer", "Lung Cancer Metastatic", "Lung Cancer Stage IV" ], "interventions": [ { "name": "BL-M14D1 and Atezolizumab", "type": "DRUG" }, { "name": "Carboplatin+ Etoposide + Atezolizumab followed by Atezolizumab and Lurbinectedin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "SystImmune Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 550, "start_date": "2026-08-04", "completion_date": "2031-06", "has_results": false, "last_update_posted_date": "2026-10-15", "last_synced_at": "2026-10-27T16:34:52.595Z", "location_count": 7, "location_summary": "Springdale, Arkansas • Glendale, California • Long Beach, California + 4 more", "locations": [ { "city": "Springdale", "state": "Arkansas" }, { "city": "Glendale", "state": "California" }, { "city": "Long Beach", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT07625644" }, { "nct_id": "NCT04007367", "title": "A Study to Evaluate SAGE-217 for Prevention of Relapse in Adult Participants With Major Depressive Disorder", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Major Depressive Disorder" ], "interventions": [ { "name": "SAGE-217", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Biogen", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 53, "start_date": "2019-08-06", "completion_date": "2020-01-06", "has_results": true, "last_update_posted_date": "2023-11-29", "last_synced_at": "2026-10-27T16:34:52.595Z", "location_count": 46, "location_summary": "Bentonville, Arkansas • Bellflower, California • Garden Grove, California + 40 more", "locations": [ { "city": "Bentonville", "state": "Arkansas" }, { "city": "Bellflower", "state": "California" }, { "city": "Garden Grove", "state": "California" }, { "city": "Lemon Grove", "state": "California" }, { "city": "Oceanside", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04007367" }, { "nct_id": "NCT00967616", "title": "Study of CS-7017 in Combination With FOLFIRI in Subjects With Metastatic Colorectal Cancer Who Failed First-Line Therapy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Colorectal Cancer", "Neoplasms, Colorectal" ], "interventions": [ { "name": "CS7017", "type": "DRUG" }, { "name": "irinotecan, leucovorin, and 5-fluorouracil (5-FU) (FOLFIRI)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Daiichi Sankyo", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 100, "start_date": "2009-09", "completion_date": "2013-04", "has_results": true, "last_update_posted_date": "2020-05-04", "last_synced_at": "2026-10-27T16:34:52.595Z", "location_count": 6, "location_summary": "Beverly Hills, California • Fullerton, California • Washington D.C., District of Columbia + 3 more", "locations": [ { "city": "Beverly Hills", "state": "California" }, { "city": "Fullerton", "state": "California" }, { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT00967616" } ] }